NAMS icon

NewAmsterdam Pharma
NAMS

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$47
37% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Guggenheim
Guggenheim
Debjit Chattopadhyay
0% 1-yr NAMS win rate
19 Feb ‘26 1 month ago
Needham
Needham
Serge Belanger
60% 1-yr NAMS win rate
18 Feb ‘26 1 month ago
RBC Capital
RBC Capital
Leonid Timashev
33% 1-yr NAMS win rate
21 Jan ‘26 2 months ago